Cite Filings / CABA / 0001470831-25-000124
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Cabaletta Bio, Inc. · Filed 2025-08-11 · Acc 0001470831-25-000124

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-08-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-13 CORRESP Correspondence Between Filers and SEC Staff
  • 2025-08-13 UPLOAD SEC-generated Letter
  • 2025-08-12 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-11 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-06 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Bain Capital Life Sciences Opportunities III, LP 9.57%
  2. 2026-11-16 SCHEDULE 13G/A · Cormorant Asset Management, LP 2.65%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…